US 11,850,303 B2
Gel and a suppository and methods to provide the gel and suppository
Spencer Gordon, San Diego, CA (US)
Assigned to Uqora, Inc., San Diego, CA (US)
Filed by Uqora, Inc., San Diego, CA (US)
Filed on Oct. 27, 2020, as Appl. No. 16/949,376.
Prior Publication US 2022/0125717 A1, Apr. 28, 2022
Int. Cl. A61K 9/06 (2006.01); A61K 9/02 (2006.01); A61K 31/191 (2006.01); A61K 31/7016 (2006.01); A61K 31/702 (2006.01); A61K 33/40 (2006.01); A61K 35/747 (2015.01)
CPC A61K 9/06 (2013.01) [A61K 9/02 (2013.01); A61K 31/191 (2013.01); A61K 31/702 (2013.01); A61K 31/7016 (2013.01); A61K 33/40 (2013.01); A61K 35/747 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A gel, the gel consisting of:
between 50 and 150 millimolar of lactic acid concentrate;
between 0.5 and 10 millimolar of hydrogen peroxide concentrate, wherein the between 50 and 150 millimolar of lactic acid concentrate is combined with the between 0.5 and 10 millimolar of hydrogen peroxide concentrates; and
optionally, at least one of a probiotic, a prebiotic, a vitamin and a moisturizer.